On April 24, 2026, TransPro Technology made a significant announcement by unveiling its groundbreaking conversational agent for protein research and development, named MatwingsVenus™ (also known as Xiaowu™). This innovative platform is built around an intelligent agent that seamlessly integrates more than 200 protein design tools, a comprehensive database boasting tens of billions of labels, and a skill library meticulously optimized by experts. Users can effortlessly issue task instructions using natural language, guiding the system through the entire computational workflow—from target discovery to performance prediction. Moreover, the platform seamlessly interfaces with automated wet lab experiments, fostering an efficient research and development paradigm characterized by 'design-and-verify, verify-and-iterate' cycles. To date, the platform has successfully accomplished multiple projects in the realms of innovative drug development and synthetic biology, marking a pivotal shift in protein R&D from being solely driven by large platforms to becoming accessible to individual researchers.